Molecular profiling of rare thymoma using next-generation sequencing: meta-analysis
, , , , , und
22. März 2023
Über diesen Artikel
Artikel-Kategorie: Review
Online veröffentlicht: 22. März 2023
Seitenbereich: 12 - 19
Eingereicht: 21. Okt. 2022
Akzeptiert: 31. Jan. 2023
DOI: https://doi.org/10.2478/raon-2023-0013
Schlüsselwörter
© 2023 Jelena Kostic Peric, Andja Cirkovic, Sanja Srzentic Drazilov, Natalija Samardzic, Vesna Skodric Trifunovic, Dragana Jovanovic, Sonja Pavlovic, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure

Figure

Figure

Figure

Figure

Figure

Figure

Characteristics of 12 selected studies
Author | Year | Study design | Thymoma | Gene (SNV) | Number of cases | number Total of cases | NGS genomics |
---|---|---|---|---|---|---|---|
23 | |||||||
12 | |||||||
22 | |||||||
Chen K, China | 2020 | Cross-sectional | Type A, AB, B1, B2, B3 | 5 | 50 | TS | |
12 | |||||||
19 | |||||||
2 | |||||||
2 | |||||||
3 | |||||||
Enkner F, Austria | 2017 | Cross-sectional | Type A, B | 1 | 19 | TS | |
1 | |||||||
Higuchi R, Japan | 2020 | Cross-sectional | Type A, AB, B | 14 | 22 | TS | |
Petrini I, Italia | 2014 | Cross-sectional | Type A, AB | 119 | 270 | ES | |
44 | |||||||
Radovich M, USA | 2017 | Case-control | Type A, AB | 10 | 105 | MOPA | |
2 | |||||||
1 | |||||||
2 | SNaPshot | ||||||
Sakane T, Japan | 2020 | Cross-sectional | Type A, B2, B3, B4, B5 | 1 | 33 | ||
1 | Multiplex | ||||||
3 | |||||||
Song ZB, China | 2016 | Type B2, B3 | 1 | 37 | TS | ||
1 | IonAmpliSeq | ||||||
27 | |||||||
27 | |||||||
Peric J, Serbia | 2020 | Case-control | Type A, B1, B2, B3 | 26 | 35 | TSACP | |
24 | |||||||
26 | |||||||
Xu S, China | 2021 | Cross-sectional | Type A, AB B1, B2, B3 | 9 | 17 | ES | |
2 | |||||||
Liang N, China | 2021 | Cross-sectional | Type A, AB, B1, B2, B3 | 15 | 24 | SureSelectXT TS | |
Szpechcinski A, Poland | 2022 | Cross-sectional | Type B2B3 | ERBBKIT 2 | 11 | 19 | TS |
KIT | 1 | ||||||
Girard N, France | 2022 | Cross-sectional | Type A, B1, B2, B3 | TPHRAS 53 | 81 | 90 | WES |
Other genes | 80 |